Amgen SVP Exercises Options, Discloses $1.19m Stock Sale

Nancy Grygiel, Senior Vice President and Chief Compliance Officer at Amgen Inc., disposed of $1.19m in stock on August 6, 2024. The transactions involved the exercise of non-qualified stock options, through which she acquired shares valued at approximately $526,906.

The sale was linked to the option exercise price and required withholding taxes associated with the expiring options. Grygiel sold an equal number of shares as she acquired, totaling 2,970 shares of common stock.

This move comes as Amgen shares trade near their 52-week high of $418.40, having delivered a 49% return over the past year. According to InvestingPro analysis, the stock remains undervalued at current levels despite the strong rally.